Merit Cost Of Revenue from 2010 to 2024

MMSI Stock  USD 104.92  0.41  0.39%   
Merit Medical's Cost Of Revenue is increasing with slightly volatile movements from year to year. Cost Of Revenue is estimated to finish at about 707.2 M this year. For the period between 2010 and 2024, Merit Medical, Cost Of Revenue quarterly trend regression had mean deviation of  175,677,294 and range of 705.5 M. View All Fundamentals
 
Cost Of Revenue  
First Reported
1991-09-30
Previous Quarter
177.3 M
Current Value
182.3 M
Quarterly Volatility
54.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 106.4 M, Interest Expense of 16.3 M or Total Revenue of 1.3 B, as well as many indicators such as Price To Sales Ratio of 2.66, Dividend Yield of 0.0 or PTB Ratio of 3.6. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
  
Check out the analysis of Merit Medical Correlation against competitors.

Latest Merit Medical's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Merit Medical Systems over the last few years. Cost of Revenue is found on Merit Medical Systems income statement and represents the costs associated with goods and services Merit Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Merit Medical's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Merit Cost Of Revenue Regression Statistics

Arithmetic Mean413,935,713
Geometric Mean282,396,259
Coefficient Of Variation50.00
Mean Deviation175,677,294
Median401,599,000
Standard Deviation206,984,880
Sample Variance42842.7T
Range705.5M
R-Value0.98
Mean Square Error1490T
R-Squared0.97
Slope45,529,757
Total Sum of Squares599798.4T

Merit Cost Of Revenue History

2024707.2 M
2023673.5 M
2022631.9 M
2021589.4 M
2020562.7 M
2019562.5 M
2018488 M

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cost Of Revenue673.5 M707.2 M

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Check out the analysis of Merit Medical Correlation against competitors.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.091
Earnings Share
2.05
Revenue Per Share
22.847
Quarterly Revenue Growth
0.078
Return On Assets
0.0456
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.